copyright® is contraindicated in patients with a private or household record of MTC or in sufferers with MEN 2, As well as in clients by using a hypersensitivity reaction to semaglutide or to any with the excipients in copyright®.Mounjaro and Zepbound are manufacturer names for a similar drug, tirzepatide. Whilst Mounjaro is permitted for form 2